References
- Friman C, Pettersson T. Amyloidosis. Curr Opin Rheumatol 1996; 8: 62–71
- Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, Ataman R, Akpolat T, Ok E, Sen S, Dusunsel R, Evrenkaya R, Akoglu E. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant 2002; 17: 2003–2005
- Hawkins P N. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002; 11: 649–655
- Hazenberg B P, van Rijswijk M H. Clinical and therapeutic aspects of AA amyloidosis. Bailliere's Clin Rheumatol 1994; 8: 661–690
- Mumford A D, O'Donnell J, Gillmore J D, Manning R A, Hawkins P N, Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 2000; 110: 454–460
- Sucker C, Hetzel G R, Grabensee B, Stockschlaeder M, Scharf R E. Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy. Am J Kidney Dis 2006; 47: 947–955
- Simckes A M, Chen S S, Osorio A V, Garola R E, Woods G M. Ketorolac-induced irreversible renal failure in sickle cell disease: a case report. Pediatr Nephrol 1999; 13: 63–67
- Warkentin T E. Heparin-induced thrombocytopenia: yet another treatment paradox?. Thromb Haemost 2001; 85: 947–949
- Olbricht C, Lonneman G, Koch K M. Haemodialysis, haemofiltration, and complication of technique. Oxford Textbook of Clinical Nephrology3rd ed, A M Davison, C S Cameron, J P Grunfeld, C Ponticelli, E Ritz, C G Winearls, C Ypersele. Oxford University Press, New York 2005; 1943
- Dulgheru E C, Balos L L, Baer A N. Gastrointestinal complications of beta2-microglobulin amyloidosis: a case report and review of the literature. Arthritis Rheum 2005; 53: 142–145
- Yood R A, Skinner M, Rubinow A, Talarico L, Cohen A S. Bleeding manifestations in 100 patients with amyloidosis. JAMA 1983; 249: 1322–1324
- Choufani E B, Sanchorawala V, Ernst T, Quillen K, Skinner M, Wright D G, Seldin D C. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood 2001; 97: 1885–1887
- Khan A Z, Escofet X, Roberts K M, Salman A R. Spontaneous splenic rupture – a rare complication of amyloidosis. Swiss Surg 2003; 9: 92–94
- Leblanc R, Carpenter S, Stewart J, Pokrupa R. Subacute enlarging cerebral hematoma from amyloid angiopathy: case report. Neurosurgery 1995; 36: 403–406
- Wanic-Kossowska M, Kobelski M, Oko A, Czekalski S. Arterial hypertension due to perirenal and subcapsular hematoma induced by renal percutaneous biopsy. Int Urol Nephrol 2005; 37: 141–143
- Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, Yamasaki S, Ida H, Kawakami A, Origuchi T, Eguchi K. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol 2003; 21: 343–346
- Sanai T, Nanishi F, Nagata M, Hirano T, Suematsu E, Esaki Y, Miyahara H, Lida M. Role of amyloidosis in determining the prognosis of dialyzed patients with rheumatoid arthritis. Rheumatol Int 2007; 27: 363–367